Sermion Indications/Uses

10 mg sugar-coated tablet: Acute or chronic, peripheral and cerebral vasculo-metabolic disorders with signs and symptoms of cerebral insufficiency or dementia, such as impaired memory and concentration, dizziness, depressed mood, impaired self-care, impaired sleep-waking cycle, disorientation in time and place, tinnitus, blurred vision, performance insufficiency, headache and fatigue (also those due to cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis in its different manifestations). Obliterative arteriopathies of the limbs: Raynaud's syndrome and all syndromes due to altered peripheral flow. Headache in geriatric arteriosclerotic subjects. As an adjuvant to therapy of arterial hypertension.
30 mg film-coated tablet: Signs and symptoms of mental deterioration, such as cognitive, affective, behavioral and somatic disturbances associated with cerebral deterioration (chronic cerebrovascular insufficiency and/or senile and pre-senile dementia, Parkinson's disease): impaired memory, decreased vigilance and impaired concentration, mood depression, apathy, interpersonal relationships, lack of self-care, asthenia, anorexia, tinnitus, dizziness; as co-adjuvant in the rehabilitative treatment of hemiplegic patients with ictus sequelae.